FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to iron (III) citrate tablets for the prevention or treatment of hyperphosphataemia. The said tablets includes a core, containing iron (III) citrate, a binding agent, a lubricant, as well as a coating, and are characterised by the fact that, at least, 80% of iron (III) citrate in them are soluble within or less than 60 min, water % in the tablets is in an interval from 5 to 12%, and tablet grateness equals 1 wt/wt % or less. The invention also relates to methods of obtaining and application of the said tablets.
EFFECT: invention provides obtaining the tablets of iron (III) citrate with the immediate release of active component.
67 cl, 9 dwg, 35 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL FORMS OF FERRIC CITRATE (III) | 2010 |
|
RU2733410C2 |
| PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2493831C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING IRON OXY-HYDROXIDE, METHOD OF PRODUCTION THEREOF AND USE | 2013 |
|
RU2648760C2 |
| SOLID MEDICINAL FORM INTENDED FOR TREATMENT OF ARTERIAL HYPERTENSIA AND STENOCARDIA, AND WAY OF ITS RECEPTION | 2008 |
|
RU2359672C1 |
| ANTITUBERCULAR COMPOSITION COMPRISING RIFAMPICIN, ISONIAZID, ETHAMBUTOL AND PYRAZINAMIDE AND PROCESS FOR PREPARATION THEREOF | 2014 |
|
RU2672879C2 |
| SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
| PELLETISABLE (4'-TRIFLUOROMETHYLPHENYL)AMIDE (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID PREPARATION WITH IMPROVED STABILITY | 2010 |
|
RU2681079C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| LAXATIVE SOLID DOSAGE FORM AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2009 |
|
RU2401106C1 |
